A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis
Authors:
- 12 October 2010
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 30 (1) , 236-248
Abstract
Poor aqueous solubility limits the therapeutic index of paclitaxel as an anti-cancer drug. Synthesis of soluble prodrugs of paclitaxel, or conjugation of the drug to macromolecular carriers have been reported to increase its water-solubility. Macromolecular drug carriers have an added advantage of targeting the drug to the tumor site due to the abnormal tumor blood and lymphatic vasculature. This study describes a thermally responsive macromolecular carrier, elastin-like polypeptide (ELP) for the delivery of paclitaxel. Paclitaxel was bound to ELP by conjugation with the 6-maleimidocaproyl hydrazone derivative of paclitaxel, an acid-sensitive paclitaxel prodrug, for the potential treatment of breast cancer. Focused hyperthermia above a specific transition temperature at the site of a tumor causes ELP to aggregate and accumulate, thereby increasing the local concentration of the drug cargo. The paclitaxel prodrug described here bears an acid-sensitive linker that is cleavable at the lysosomal/endosomal pH, which allows a controlled intracellular release of the drug. The ELP-delivered paclitaxel in the presence of hyperthermia inhibits MCF-7 cell proliferation by stabilizing the microtubule structures, arresting the cells at the G2/M stage, and inducing apoptosis in a manner similar to conventional paclitaxel. It also inhibits proliferation of a paclitaxel resistant MCF-7 cell line. These data provide an in vitro proof of concept for the use of ELP as a delivery vehicle of paclitaxel.Keywords
This publication has 36 references indexed in Scilit:
- A thermally targeted peptide inhibitor of symmetrical dimethylation inhibits cancer-cell proliferationPeptides, 2010
- Elastin‐like polypeptides: Biomedical applications of tunable biopolymersPeptide Science, 2010
- Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrierInternational Journal of Cancer, 2009
- Application of Thermally Responsive Elastin-like Polypeptide Fused to a Lactoferrin-derived Peptide for Treatment of Pancreatic CancerMolecules, 2009
- A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistanceInvestigational New Drugs, 2007
- Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude miceJournal of Controlled Release, 2006
- cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistanceBreast Cancer Research and Treatment, 2005
- Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug deliveryJournal of Controlled Release, 2005
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Entropic elastic processes in protein mechanisms. I. Elastic structure due to an inverse temperature transition and elasticity due to internal chain dynamicsThe Protein Journal, 1988